Topical antimicrobial dressings for infected leg ulcers in people 16 years and over: late-stage assessment
Closed for comments This consultation ended on at Request commenting lead permission
HTE10041 Draft Guidance - Topical Antimicrobial dressings for wound care (late stage assessment) v1.1 [noACIC].docx
Guidance development process
NICE late-stage assessment (LSA) guidance evaluates categories of technologies that are already in widespread use within the NHS. It assesses whether price variations between technologies in a category are justified by differences in innovation, clinical effectiveness and patient benefits. This will support NHS commissioners, procurement teams, patients and healthcare professionals to choose technologies that maximise clinical effectiveness and value for money.
Find out more on the NICE webpage on late-stage assessment (LSA) for medtech.
NICE is producing this guidance on topical antimicrobial dressings for infected leg ulcers in people aged 16 years and over in the NHS in England. The medical technologies advisory committee has considered the evidence and the views of clinical and patient experts.
This document has been prepared for consultation with the stakeholders. It summarises the evidence and views that have been considered, and sets out the recommendations made by the committee. NICE invites comments from the stakeholders for this evaluation and the public. This document should be read along with the evidence.
The committee is interested in receiving comments on the following:
Has all of the relevant evidence been taken into account?
Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
Are the recommendations sound and a suitable basis for guidance to the NHS?
Are there any aspects of the recommendations that need particular consideration to ensure we avoid unlawful discrimination against any group of people on the grounds of age, disability, gender reassignment, pregnancy and maternity, race, religion or belief, sex or sexual orientation?
After consultation:
Based on the consultation comments received, the committee may meet again.
If committee meets again it will consider the evidence, this evaluation consultation document and comments from stakeholders.
The committee will then prepare the final draft guidance, which will go through a resolution process before the final guidance is agreed.
Note that this document is not NICE's final guidance on Topical antimicrobial dressings for infected leg ulcers in people aged 16 years and over. The recommendations in section 1 may change after consultation.
More details are available in NICE's health technology evaluations: the manual and NICE's late-stage assessment interim process and methods statement.
Key dates:
Closing date for comments: 28/02/2024
Second committee meeting: 20/03/2024
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions